You are here

Research Worth Watching

Research Worth Watching: Using DNA to Optimize Treatment and Reduce Collateral Damage

One major problem from much of our cancer therapy is the collateral damage. Not the side effects, such as nausea and vomiting or hair loss, which are typically transient but the long-term consequences of therapy, such as chemobrain and neuropathy.  Some of these changes will resolve and many will not. In my case, it’s been six years since I received chemotherapy to treat my leukemia, and my sense of taste and smell still haven’t returned.

Exercise and Breast Cancer Protection: What, Why and How?

We all know exercise is fantastic for us physically and mentally. Exercise helps to maintain a healthy weight, strengthens bones and muscles, reduces the risk of cardiovascular disease, Type 2 diabetes and metabolic syndrome, improves the ability to do daily activities and improves mental health and mood. Maybe surprising to some, is that exercise also reduces the risk of certain cancers, including breast cancer initiation and recurrence.

Research Worth Watching: New Treatments for Brain Metastases

Breast cancer becomes deadly when it metastasizes—spreads to other parts of the body. For decades, we’ve been focused on developing treatments that will keep early-stage breast cancer from recurring. Now, researchers are spending more time studying how and where cancer cells spreads, with the goal of developing treatments that may cure, or at least stabilize, metastatic breast cancer

Research Worth Watching: The 9th International Symposium on the Breast

It is hard for me to believe that it has been almost two weeks since our 9th International Symposium! We first hosted this conference in 1999 and, while each year has been special, I think this year’s meeting, “Exploring the Human Breast: Employing New Technology,” was one of the best yet!

Research Worth Watching: What Type of Breast Cancer Do You Have? The Answer May Change Over Time

To determine what type of breast cancer you have and how it should be treated, your tumor is tested to see if it has hormone receptors (ER and PR positive or negative) and if it overproduces the HER2 protein (HER2 positive or negative).

Research Worth Watching - Precision Medicine and Collateral Damage

Dr. Susan Love Research Foundation is actively preparing for our Metastatic Breast Cancer Collateral Damage Project Two-Day Think Tank, which is taking place November 10-11. At the Think Tank, we will present the data we have collected on the collateral damage associated with metastatic breast cancer and its treatments. We will also discuss and develop recommendations that can be implemented within our current healthcare system to improve the lives of those living with metastatic disease. 

Pages